Advertisement
Screener

Perrigo Company plc (PRGO) Increase (Decrease) in Operating Capital

2.8 / 5 stars · 68/120 Roast Me

Perrigo Company plc Increase (Decrease) in Operating Capital

Perrigo Company plc (PRGO) reported Increase (Decrease) in Operating Capital of $160.30 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2026-08-05

  • Perrigo Company plc increase (decrease) in operating capital for the quarter ending 2026-06-27 was -$36.00M, a 209.76% decline year-over-year.
  • Perrigo Company plc increase (decrease) in operating capital for the quarter ending 2026-03-28 was $196.30M, a 9.42% increase year-over-year.
  • Perrigo Company plc increase (decrease) in operating capital for the quarter ending 2025-12-31 was -$158.80M.
  • Perrigo Company plc increase (decrease) in operating capital for the quarter ending 2025-09-27 was $47.70M, a 171.02% increase year-over-year.
  • Perrigo Company plc increase (decrease) in operating capital for fiscal 2025 was $101.10M, a 35.34% increase from fiscal 2024.
  • Perrigo Company plc increase (decrease) in operating capital for fiscal 2024 was $74.70M, a 27.69% increase from fiscal 2023.
  • Perrigo Company plc increase (decrease) in operating capital for fiscal 2023 was $58.50M.
  • Perrigo Company plc increase (decrease) in operating capital for fiscal 2022 was -$20.00M, a 106.77% decline from fiscal 2021.
Period endIncrease (Decrease) in Operating Capital 3 monthIncrease (Decrease) in Operating Capital 3 month as first filedIncrease (Decrease) in Operating Capital 6 monthIncrease (Decrease) in Operating Capital 6 month as first filedIncrease (Decrease) in Operating Capital 9 monthIncrease (Decrease) in Operating Capital 9 month as first filedIncrease (Decrease) in Operating Capital 12 monthIncrease (Decrease) in Operating Capital 12 month as first filed
2026-06-27-$36.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$160.30M
10-Q · filed 2026-08-05
$1.50M
derived: sum of 3 quarters · filed 2026-08-05
$49.20M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28$196.30M
10-Q · filed 2026-05-06
$37.50M
derived: sum of 2 quarters · filed 2026-05-06
$85.20M
derived: sum of 3 quarters · filed 2026-05-06
$118.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$158.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$111.10M
derived: sum of 2 quarters · filed 2026-02-26
-$78.30M
derived: sum of 3 quarters · filed 2026-08-05
$101.10M
10-K · filed 2026-02-26
2025-09-27$47.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$80.50M
derived: sum of 2 quarters · filed 2026-08-05
$259.90M
10-Q · filed 2025-11-05
$98.10M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28$32.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$212.20M
10-Q · filed 2026-08-05
$214.60M
10-Q · filed 2025-08-06
$50.40M
derived: sum of 3 quarters · filed 2026-08-05
$68.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$179.40M
10-Q · filed 2026-05-06
$176.40M
10-Q · filed 2025-05-07
$17.60M
derived: sum of 2 quarters · filed 2026-05-06
$35.20M
derived: sum of 3 quarters · filed 2026-05-06
$127.40M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$161.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$144.20M
derived: sum of 2 quarters · filed 2026-02-26
-$52.00M
derived: sum of 3 quarters · filed 2026-02-26
$74.70M
10-K · filed 2026-02-26
2024-09-28$17.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$109.80M
derived: sum of 2 quarters · filed 2025-11-05
$236.50M
10-Q · filed 2025-11-05
$107.30M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-29$92.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$218.90M
10-Q · filed 2025-08-06
$89.70M
derived: sum of 3 quarters · filed 2026-02-26
$110.80M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-30$126.70M
10-Q · filed 2025-05-07
-$2.50M
derived: sum of 2 quarters · filed 2026-02-26
$18.60M
derived: sum of 3 quarters · filed 2026-02-26
$97.30M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$129.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$108.10M
derived: sum of 2 quarters · filed 2026-02-26
-$29.40M
derived: sum of 3 quarters · filed 2026-02-26
$58.50M
10-K · filed 2026-02-26
2023-09-30$21.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$99.80M
derived: sum of 2 quarters · filed 2024-11-06
$187.70M
10-Q · filed 2024-11-06
$69.60M
derived: sum of 4 quarters · filed 2025-02-28
2023-07-01$78.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
$166.60M
10-Q · filed 2024-08-02
$48.50M
derived: sum of 3 quarters · filed 2025-02-28
$34.50M
derived: sum of 4 quarters · filed 2025-02-28
2023-04-01$87.90M
10-Q · filed 2024-05-07
-$30.20M
derived: sum of 2 quarters · filed 2025-02-28
-$44.20M
derived: sum of 3 quarters · filed 2025-02-28
$67.00M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$118.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$132.10M
derived: sum of 2 quarters · filed 2025-02-28
-$20.90M
derived: sum of 3 quarters · filed 2025-02-28
-$20.00M
10-K · filed 2025-02-28
2022-10-01-$14.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$97.20M
derived: sum of 2 quarters · filed 2023-11-07
$98.10M
10-Q · filed 2023-11-07
$352.20M
derived: sum of 4 quarters · filed 2024-02-27
2022-07-02$111.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$112.10M
10-Q · filed 2023-08-08
$366.20M
derived: sum of 3 quarters · filed 2024-02-27
-$20.70M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-02$900.00K
10-Q · filed 2023-05-09
$255.00M
derived: sum of 2 quarters · filed 2024-02-27
-$131.90M
derived: sum of 3 quarters · filed 2024-02-27
$156.00M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$254.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
-$132.80M
derived: sum of 2 quarters · filed 2024-02-27
$155.10M
derived: sum of 3 quarters · filed 2024-02-27
$295.40M
10-K · filed 2024-02-27
2021-10-02-$386.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$99.00M
derived: sum of 2 quarters · filed 2022-11-08
$41.30M
10-Q · filed 2022-11-08
$66.30M
derived: sum of 4 quarters · filed 2023-02-28
2021-07-03$287.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$428.20M
10-Q · filed 2022-08-09
$453.20M
derived: sum of 3 quarters · filed 2023-02-28
$561.90M
derived: sum of 4 quarters · filed 2023-02-28
2021-04-03$140.30M
10-Q · filed 2022-05-11
$165.30M
derived: sum of 2 quarters · filed 2023-02-28
$274.00M
derived: sum of 3 quarters · filed 2023-02-28
$175.20M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$25.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$133.70M
derived: sum of 2 quarters · filed 2023-02-28
$34.90M
derived: sum of 3 quarters · filed 2023-02-28
$69.20M
10-K · filed 2023-02-28
2020-09-26$108.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$9.90M
derived: sum of 2 quarters · filed 2021-11-12
$44.20M
10-Q · filed 2021-11-12
$133.00M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-27-$98.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$64.50M
10-Q · filed 2021-08-11
$24.30M
derived: sum of 3 quarters · filed 2022-03-01
$44.80M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-28$34.30M
10-Q · filed 2021-05-12
$123.10M
derived: sum of 2 quarters · filed 2022-03-01
$143.60M
derived: sum of 3 quarters · filed 2022-03-01
$251.00M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$88.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$109.30M
derived: sum of 2 quarters · filed 2022-03-01
$216.70M
derived: sum of 3 quarters · filed 2022-03-01
$313.50M
10-K · filed 2022-03-01
2019-09-28$20.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$127.90M
derived: sum of 2 quarters · filed 2020-11-05
$224.70M
10-Q · filed 2020-11-05
$70.00M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-29$107.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$204.20M
10-Q · filed 2020-08-05
$49.50M
derived: sum of 3 quarters · filed 2021-03-01
$117.60M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-30$96.80M
10-Q · filed 2020-05-05
-$57.90M
derived: sum of 2 quarters · filed 2021-03-01
$10.20M
derived: sum of 3 quarters · filed 2021-03-01
$71.20M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$154.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$86.60M
derived: sum of 2 quarters · filed 2021-03-01
-$25.60M
derived: sum of 3 quarters · filed 2021-03-01
$19.40M
10-K · filed 2021-03-01
2018-09-29$68.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$129.10M
derived: sum of 2 quarters · filed 2019-11-06
$174.10M
10-Q · filed 2019-11-06
$152.80M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$61.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$106.00M
10-Q · filed 2019-08-08
$84.70M
derived: sum of 3 quarters · filed 2020-02-27
$50.90M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$45.00M
10-Q · filed 2019-05-09
$23.70M
derived: sum of 2 quarters · filed 2020-02-27
-$10.10M
derived: sum of 3 quarters · filed 2020-02-27
$176.00M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$21.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$55.10M
derived: sum of 2 quarters · filed 2020-02-27
$131.00M
derived: sum of 3 quarters · filed 2020-02-27
$103.90M
10-K · filed 2020-02-27
2017-09-30-$33.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$152.30M
derived: sum of 2 quarters · filed 2018-11-08
$125.20M
10-Q · filed 2018-11-08
$99.20M
derived: sum of 4 quarters · filed 2019-02-27
2017-07-01$186.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$159.00M
10-Q · filed 2018-08-09
$133.00M
derived: sum of 3 quarters · filed 2019-02-27
$89.90M
derived: sum of 4 quarters · filed 2019-02-27
2017-04-01-$27.10M
10-Q · filed 2018-05-08
-$53.10M
derived: sum of 2 quarters · filed 2019-02-27
-$96.20M
derived: sum of 3 quarters · filed 2019-02-27
$145.90M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$26.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$69.10M
derived: sum of 2 quarters · filed 2019-02-27
$173.00M
derived: sum of 3 quarters · filed 2019-02-27
$101.50M
10-K · filed 2019-02-27
2016-10-01-$43.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$199.00M
derived: sum of 2 quarters · filed 2017-11-09
$127.50M
10-Q · filed 2017-11-09
$146.90M
10-Q · filed 2016-11-10
$90.80M
derived: sum of 4 quarters · filed 2018-03-01
2016-07-02$242.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$170.60M
10-Q · filed 2017-08-10
$167.00M
10-Q · filed 2016-08-10
$133.90M
derived: sum of 3 quarters · filed 2018-03-01
$291.40M
derived: sum of 4 quarters · filed 2018-03-01
2016-04-02-$71.50M
10-Q · filed 2017-05-30
$27.80M
10-Q · filed 2016-05-16
-$108.20M
derived: sum of 2 quarters · filed 2018-03-01
$49.30M
derived: sum of 3 quarters · filed 2018-03-01
-$117.80M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$36.70M
derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01
$120.80M
10-K · filed 2018-03-01
$154.30M
10-KT · filed 2016-02-25
-$46.30M
derived: sum of 3 quarters · filed 2018-03-01
-$20.70M
derived: sum of 4 quarters · filed 2018-03-01
2015-09-26$157.50M
10-Q · filed 2015-11-02
-$9.60M
derived: sum of 2 quarters · filed 2017-05-22
$0.00
10-Q/A · filed 2017-05-23
$34.60M
10-Q · filed 2016-11-10
-$27.00M
derived: sum of 4 quarters · filed 2017-05-22
2015-06-27-$167.10M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22
-$141.50M
10-Q/A · filed 2017-05-22
-$122.70M
10-Q · filed 2016-08-10
-$184.50M
derived: sum of 3 quarters · filed 2017-05-22
-$164.40M
10-K · filed 2018-03-01
-$147.30M
10-K · filed 2015-08-13
2015-03-28$25.60M
10-Q/A · filed 2017-05-22
$25.00M
10-Q · filed 2016-05-16
-$17.40M
derived: sum of 2 quarters · filed 2017-05-22
$600.00K
10-Q · filed 2015-04-29
-$115.70M
derived: sum of 4 quarters · filed 2017-05-22
2014-12-27-$43.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05
-$24.50M
10-Q · filed 2015-02-05
-$141.30M
derived: sum of 3 quarters · filed 2017-05-22
-$148.10M
derived: sum of 4 quarters · filed 2017-05-22
2014-09-27$18.50M
10-Q · filed 2015-11-02
-$98.30M
derived: sum of 2 quarters · filed 2017-05-22
-$105.10M
derived: sum of 3 quarters · filed 2017-05-22
-$50.20M
derived: sum of 4 quarters · filed 2017-05-22
2014-06-28-$116.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22
-$123.60M
derived: sum of 2 quarters · filed 2017-05-22
-$68.70M
derived: sum of 3 quarters · filed 2017-05-22
-$20.50M
10-K · filed 2017-05-22
$64.80M
10-K · filed 2014-08-14
2014-03-29-$6.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29
$48.10M
derived: sum of 2 quarters · filed 2015-04-29
$96.30M
10-Q · filed 2015-04-29
$112.00M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-28$54.90M
derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05
$103.10M
10-Q · filed 2015-02-05
$118.80M
derived: sum of 3 quarters · filed 2016-02-25
$124.20M
derived: sum of 4 quarters · filed 2016-02-25
2013-09-28$48.20M
8-K · filed 2014-11-20
$63.90M
derived: sum of 2 quarters · filed 2016-02-25
$69.30M
derived: sum of 3 quarters · filed 2016-02-25
2013-06-29$15.70M
derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25
$21.10M
derived: sum of 2 quarters · filed 2016-02-25
$71.80M
10-KT · filed 2016-02-25
2013-03-30$5.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07
$56.10M
10-Q · filed 2014-05-07
2012-12-29$50.70M
10-Q · filed 2014-02-06
2012-06-30$51.80M
10-K · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38